Drug Trial Radar · NCT07088926
A Study to Evaluate the Efficacy, Safety, and PK of AZD0292 Administered IV in Participants 12 Years of Age and Older With Bronchiectasis and Chronic Pseudomonas Aeruginosa Colonization
Last checked: Nov 19, 2026Latest source record: Oct 2, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
435
Planned (sponsor's estimate)
Start
Nov 6, 2025
Primary completion
Dec 9, 2027
Study completion Jun 14, 2028
Sponsor
- Lead sponsor
- AstraZenecaAstraZeneca (AZN)
- Sponsor type
- Industry
- First posted
- Jul 28, 2025
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Prevention
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 12 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
AZD0292 is a bispecific IgG1k mAb being evaluated for the prevention of exacerbations in bronchiectasis patients chronically colonized with PsA.
Conditions
- Bronchiectasis With Pseudomonas Aeruginosa Colonization
Interventions
AZD0292Biological
AZD0292 high-dose or low-dose administered starting on Day 1 via IV infusion, subsequent administrations per schedule of assessments.
PlaceboOther
Placebo administered starting on Day 1 via IV infusion, subsequent administrations per schedule of assessments.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Annualized rate of exacerbations over a variable follow-up timeTime frame: Min 28 weeks, max 52 weeks
Locations
186 sites in 25 countries. Site status is shown where the registry gives one.
Research Site
Orange, California · Recruiting
Research Site
San Francisco, California · Recruiting
Research Site
Denver, Colorado · Not yet recruiting
Research Site
Washington D.C., District of Columbia · Recruiting
Research Site
Jacksonville, Florida · Recruiting
Research Site
Miami Lakes, Florida · Terminated
Research Site
Naples, Florida · Recruiting
Research Site
Ormond Beach, Florida · Recruiting
Research Site
Plantation, Florida · Recruiting
Research Site
Rincon, Georgia · Recruiting
Research Site
Kansas City, Kansas · Recruiting
Research Site
Ann Arbor, Michigan · Recruiting
Research Site
Detroit, Michigan · Withdrawn
Research Site
Rochester, Minnesota · Withdrawn
Research Site
St Louis, Missouri · Recruiting
Research Site
New York, New York · Recruiting
Research Site
New Bern, North Carolina · Recruiting
Research Site
Winston-Salem, North Carolina · Not yet recruiting
Research Site
Tulsa, Oklahoma · Withdrawn
Research Site
DuBois, Pennsylvania · Withdrawn
Research Site
Philadelphia, Pennsylvania · Recruiting
Research Site
Charleston, South Carolina · Recruiting
Research Site
Rock Hill, South Carolina · Withdrawn
Research Site
Austin, Texas · Withdrawn
Research Site
Mansfield, Texas · Recruiting
Research Site
Ciudad de Buenos Aires, Argentina · Recruiting
Research Site
Florida, Argentina · Recruiting
Research Site
Rosario, Argentina · Recruiting
Research Site
San Miguel de Tucumán, Argentina · Recruiting
Research Site
Birtinya, Australia · Recruiting
Research Site
Macquarie University, Australia · Recruiting
Research Site
South Brisbane, Australia · Recruiting
Research Site
Ghent, Belgium · Recruiting
Research Site
Leuven, Belgium · Recruiting
Research Site
Liège, Belgium · Recruiting
Research Site
Sint-Niklaas, Belgium · Recruiting
Research Site
Blumenau, Brazil · Recruiting
Research Site
Campinas, Brazil · Recruiting
Research Site
Curitiba, Brazil · Recruiting
Research Site
Curitiba, Brazil · Recruiting
Showing 40 of 186 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.